Zofran (ondansetron) is not dangerous for most people when used as directed. It’s one of the most commonly prescribed anti-nausea medications in the world, used millions of times a year for chemotherapy, surgery recovery, and pregnancy-related nausea. That said, it does carry real risks in specific situations, particularly for people with certain heart conditions, those taking antidepressants, or those considering it during early pregnancy.
Common Side Effects
The most frequent side effect of Zofran is headache. In clinical trials for moderately emetogenic chemotherapy, headache occurred in about 24% to 27% of patients taking ondansetron, compared to 13% of those on placebo. For postoperative nausea, the headache rate was lower, around 9%. Constipation is the other commonly reported issue, affecting roughly 6% to 9% of patients in those same chemotherapy trials versus less than 1% on placebo.
Beyond those two, most people tolerate the drug well. Fatigue, dizziness, and mild warmth or flushing occur occasionally but aren’t common enough to show up at high rates in trials. For short-term use of a few days, serious side effects are rare.
Heart Rhythm Concerns
The most significant safety warning on Zofran involves its potential to affect heart rhythm. The drug can slightly extend the QT interval, a measurement of electrical activity in the heart. When the QT interval stretches too long, it raises the risk of a dangerous irregular heartbeat.
At standard oral doses, this effect is minimal for healthy people. FDA data shows that an 8 mg intravenous dose did not prolong the QT interval to any clinically relevant extent. Higher intravenous doses (24 mg) showed more noticeable changes, and a rapid 32 mg IV infusion was linked to a case of transient heart block. For context, most people taking Zofran orally for nausea are getting 4 to 16 mg, well below those thresholds.
The concern is greater if you have congenital long QT syndrome (a genetic heart rhythm condition), low potassium or magnesium levels, heart failure, or if you take other medications that also affect heart rhythm. If any of those apply to you, your prescriber should know before you start Zofran.
Risks When Combined With Antidepressants
Zofran works by blocking serotonin receptors in the body. That mechanism overlaps with SSRIs (like sertraline and fluoxetine) and SNRIs (like venlafaxine), which increase serotonin activity in the brain. Taking both together can, in rare cases, trigger serotonin syndrome, a potentially serious condition caused by too much serotonin activity.
Serotonin syndrome symptoms include confusion, rapid heart rate, high body temperature, muscle twitching or rigidity, sweating, and diarrhea. Some reported cases have been fatal, though the condition remains rare. The risk is highest when starting a new medication or increasing a dose. If you’re on an antidepressant and are prescribed Zofran, your provider should be monitoring for these symptoms, but it’s worth flagging the combination yourself if no one has mentioned it.
Safety During Pregnancy
This is where the picture gets complicated. Zofran is widely prescribed off-label for morning sickness, but its safety in the first trimester remains genuinely uncertain. Studies looking at whether ondansetron increases the risk of oral-facial clefts (like cleft palate) or heart defects in newborns have produced conflicting results.
A 2021 review in JAMA Network Open found that estimates for cleft-related risk ranged from no increased risk at all (risk ratio of 0.95) to more than double the risk (odds ratio of 2.37), depending on the study. For cardiac defects, results were similarly mixed, ranging from no increase to roughly double the risk for one specific type of heart defect. The inconsistency across studies makes it hard to draw firm conclusions either way.
What this means practically: Zofran is not a first-line treatment for pregnancy nausea. Other options with longer safety track records, like vitamin B6 combined with doxylamine, are typically recommended first. When those don’t work and nausea is severe enough to cause dehydration or weight loss, the potential benefits of Zofran may outweigh the uncertain risks.
Long-Term Use
Zofran was designed for short-term use, typically one to five days around a chemotherapy cycle, surgery, or radiation treatment. A review by the Canadian Agency for Drugs and Technologies in Health found no published evidence on the long-term safety of ondansetron for nausea prevention and noted that this class of drug is not suggested for use beyond five days.
That doesn’t necessarily mean long-term use is harmful. Some studies looking at ondansetron used over longer periods for other conditions (not nausea) didn’t find higher rates of adverse events. But the honest answer is that the data simply doesn’t exist to confidently say extended daily use is safe. If you’re relying on Zofran regularly for weeks or months, that’s a conversation worth having with your prescriber about whether an alternative approach might be better.
Who Should Be Cautious
For the average person taking Zofran for a few days after surgery or during a stomach bug, the drug has a strong safety profile. The people who need to be more careful fall into a few specific groups:
- People with heart rhythm conditions, especially congenital long QT syndrome, where Zofran should be avoided entirely.
- People taking SSRIs or SNRIs, due to the small but real risk of serotonin syndrome.
- People with severe liver disease, since the liver is responsible for breaking down ondansetron and impaired function can lead to higher drug levels in the body.
- People in the first trimester of pregnancy, where the risk-benefit calculation is more nuanced and alternatives should be tried first.
- People with low electrolyte levels, particularly potassium or magnesium, which can amplify the heart rhythm effects.
Outside of these groups, Zofran is one of the better-tolerated anti-nausea medications available. A headache or a day of constipation is the typical worst-case scenario for most users.